Jean‐François Abgrall
- Internal Medicine top 1%
- Venous Thromboembolism Diagnosis and Management 7
- Hematology top 1%
- Acute Myeloid Leukemia Research 6
- Platelet Disorders and Treatments 5
- Blood Coagulation and Thrombosis Mechanisms 5
- Chronic Myeloid Leukemia Treatments 4
- Genetics top 5%
- Myeloproliferative Neoplasms: Diagnosis and Treatment 6
- Coagulation, Bradykinin, Polyphosphates, and Angioedema 4
- Gastroenterology top 5%
-
- Eosinophilic Disorders and Syndromes 4
Jean‐François Abgrall
34 papers receiving 2.0k citations
Hit Papers
Peers
Comparison fields: 5 of 92
- Internal Medicine 413
- Hematology 821
- Cardiology and Cardiovascular Medicine 785
- Genetics 328
- Gastroenterology 141
Countries citing papers authored by Jean‐François Abgrall
This map shows the geographic impact of Jean‐François Abgrall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean‐François Abgrall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean‐François Abgrall more than expected).
Fields of papers citing papers by Jean‐François Abgrall
This network shows the impact of papers produced by Jean‐François Abgrall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean‐François Abgrall. The network helps show where Jean‐François Abgrall may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jean‐François Abgrall, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 34 | |
| 2 | 2013 | 41 | |
| 3 | 2013 | 57 | |
| 4 | 2011 | 11 | |
| 5 | 2011 | 36 | |
| 6 | 2010 | 51 | |
| 7 | Influence of Omeprazole on the Antiplatelet Action of Clopidogrel Associated With Aspirinbreakdown → | 2008 | 720 |
| 8 | 2008 | 101 | |
| 9 | 2004 | 2 | |
| 10 | 2003 | 41 | |
| 11 | 2003 | 10 | |
| 12 | 1998 | 85 | |
| 13 | 1998 | 40 | |
| 14 | 1998 | 102 | |
| 15 | 1997 | 40 | |
| 16 | 1997 | 10 | |
| 17 | 1996 | 35 | |
| 18 | 1993 | 19 | |
| 19 | 1993 | 13 | |
| 20 | 1992 | 3 |
About Jean‐François Abgrall
Jean‐François Abgrall is a scholar working on Internal Medicine, Hematology and Genetics, having authored 34 papers that have together received 2.1k indexed citations. Recurring topics across this work include Venous Thromboembolism Diagnosis and Management (7 papers), Acute Myeloid Leukemia Research (6 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers), Platelet Disorders and Treatments (5 papers), Blood Coagulation and Thrombosis Mechanisms (5 papers), Eosinophilic Disorders and Syndromes (4 papers), Chronic Myeloid Leukemia Treatments (4 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (4 papers). The work is most often cited by research in Internal Medicine (413 citations), Hematology (821 citations) and Cardiology and Cardiovascular Medicine (785 citations). Jean‐François Abgrall has collaborated with scholars based in France, Belgium and Austria. Frequent co-authors include Dominique Mottier, Karine Lacut, Grégoire Le Gal, Geneviève Le Calvez, Jean‐Christophe Cornily, Jacques Mansourati, Martine Gilard, J Boschat, Arnaud Bertrand and Emmanuel Oger. Their work appears in journals such as Blood, Journal of the American College of Cardiology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.